Why Is Badger Meter (BMI) Stock Down -11.89% Today?
Key Takeaways
- Badger Meter shares plummeted approximately 11.89% on Wednesday, July 22, 2026, falling from a prior close of $145.87 to roughly $128.53 in afternoon trading.
- The primary catalyst was the company's Q2 2026 earnings report, which showed a 7% year-over-year revenue decline and a 13% drop in diluted EPS, despite meeting analyst consensus estimates.
- Management's cautious "flattish" full-year organic revenue guidance disappointed investors who had hoped for a stronger second-half recovery trajectory.
- Margin compression, lower free cash flow, and ongoing AMI project pacing uncertainty compounded negative sentiment around the water technology company.
- Broader industrial and water infrastructure sector weakness added to the selling pressure, with elevated trading volume confirming institutional repositioning.
- Traders are now focused on whether awarded municipal projects ramp as scheduled in H2 2026 and whether cost pressures from electronics components ease.
Opening Summary
BMI, the stock of Badger Meter, Inc. — a Milwaukee-based global manufacturer of flow measurement, water quality, and control solutions for municipal water utilities and industrial customers — suffered a sharp decline of approximately 11.89% in Wednesday's trading session. The stock fell from a previous close of $145.87 to roughly $128.53 as of mid-afternoon, erasing a significant portion of recent gains. The sell-off was triggered by the company's second quarter 2026 earnings release, which, while in line with Wall Street estimates, revealed ongoing year-over-year deterioration in sales, earnings, and operating margins, paired with a cautious full-year outlook that left investors uninspired.
Earnings Miss the Mark on Sentiment Despite Meeting Estimates
Badger Meter reported Q2 2026 diluted earnings per share of $1.02, down 13% from $1.17 in the prior-year quarter but matching the consensus analyst estimate of approximately $1.02. Revenue came in at $222.3 million, a 7% decline from $238.1 million a year ago, and slightly above the $220–221 million consensus forecast. While these headline numbers did not constitute a formal miss, the year-over-year contraction in both top- and bottom-line performance weighed heavily on investor sentiment.
Operating earnings fell 12% to $39.4 million, with operating margins compressing 110 basis points to 17.7% from 18.8% in the year-ago period. Gross margin slipped 30 basis points to 40.8%, held within the company's normalized range of 39–42% but pressured by lower sales volumes and project mix effects. Free cash flow fell sharply to $21.9 million from $40.6 million a year earlier, reflecting temporary working capital increases tied to uneven project pacing.
"Flattish" Full-Year Guidance Dampens Recovery Hopes
Perhaps the most significant weight on the stock was management's reaffirmed outlook for full-year organic revenue to be "flattish" compared to 2025 levels, excluding the contribution from the recently acquired UDlive Limited. CEO Kenneth C. Bockhorst emphasized that sequential quarterly improvement was expected through the remainder of 2026, but the cautious tone around annual growth — particularly against a backdrop where some analysts had modeled more robust second-half acceleration — appeared to disappoint the market.
CFO Dan Weltzin also flagged "increasing levels of electronic component cost and availability pressures" stemming from AI and data center build-out demand, signaling that margin headwinds may persist. The combination of tepid growth guidance and ongoing cost pressures gave investors little reason to bid the stock higher in the immediate aftermath of the report.
Segment Dynamics: Utility Water Weakness, Flow Instrumentation a Bright Spot
Utility water sales — Badger Meter's largest segment — declined 8% year-over-year (9% excluding the UDlive acquisition), driven by the uneven ramp of advanced metering infrastructure (AMI) projects. On a positive note, utility water sales improved 8% sequentially from the first quarter, as several previously awarded projects, including the major PRASA initiative in Puerto Rico, began initial product shipments.
Flow instrumentation products provided a relative bright spot, with sales rising 6% year-over-year, supported by broad-based water application demand and emerging orders tied to data center cooling and flow monitoring. However, this segment alone was insufficient to offset the drag from the larger utility water business.
Market Context and Trading Activity
Trading volume in BMI was significantly elevated on Wednesday, running well above the stock's average daily volume, indicating heavy institutional repositioning following the earnings release. The sell-off in Badger Meter shares occurred against a backdrop of broader caution in industrial and water infrastructure names, as investors reassess the pace of municipal capital spending and the potential impact of sustained higher interest rates on project financing timelines.
The magnitude of the decline — pushing below key technical support levels near $138–140 — suggests that momentum-driven selling amplified the fundamental disappointment. The stock had rallied considerably in recent weeks leading into the earnings report, leaving it vulnerable to a sharp reversal when the results and guidance failed to exceed expectations.
Trending AI Robots
For traders seeking systematic, data-driven approaches to navigate volatile markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron provides hundreds of AI-powered trading bots covering thousands of tickers across equities, ETFs, and cryptocurrencies, but only the strongest performers under current market conditions are highlighted in this dedicated section. These bots differ by strategy — from swing trading to trend following — as well as timeframe, performance metrics, and the symbols they trade. The Trending AI Robots section serves as a streamlined discovery tool for traders who want to identify which automated strategies are delivering results right now, without sifting through the entire bot marketplace. Explore the Trending AI Robots page to see which strategies are currently leading the pack.
What Comes Next for BMI
Looking ahead, the key variable for BMI will be whether the company's pipeline of awarded AMI projects materializes on schedule during the second half of 2026. Management has indicated that the cohort of nine previously discussed awarded projects "feels pretty solid," with initial shipments already underway for several. Any positive updates on project ramp timelines could help restore investor confidence.
Additionally, the integration of UDlive — the UK-based sewer line monitoring specialist acquired in May 2026 — will be closely watched, as it expands Badger Meter's beyond-the-meter capabilities. On the risk side, ongoing class action litigation related to prior-period disclosures, electronic component cost inflation, and the inherent unpredictability of municipal procurement cycles all represent uncertainties that could keep the stock range-bound in the near term. The next quarterly report will be a critical checkpoint for whether the recovery narrative remains intact.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BMI saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for BMI moved out of overbought territory on July 21, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 61 similar instances where the indicator exited the overbought zone. In of the 61 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for BMI moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMI as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BMI broke above its upper Bollinger Band on June 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on June 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 220 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.165) is normal, around the industry mean (4.427). P/E Ratio (33.002) is within average values for comparable stocks, (90.232). Projected Growth (PEG Ratio) (3.645) is also within normal values, averaging (2.334). Dividend Yield (0.011) settles around the average of (0.011) among similar stocks. P/S Ratio (4.801) is also within normal values, averaging (26.741).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments
Advertisement